Jeffrey G. Lamothe

Companies

• Aptevo Therapeutics Inc.Board member Aug 10, 2026 to now¹
• Aptevo Therapeutics Inc.Chief executive officer Aug 10, 2026 to now¹
• Aptevo Therapeutics Inc.President Aug 10, 2026 to now¹
• Aptevo Therapeutics Inc.Chief operating officer Mar 7, 2023 to now²
• Aptevo Therapeutics Inc.Chief financial officer Aug 2, 2016 to Jan 30, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAptevo Therapeutics Inc. APVO961 shares⁴$1.5K at $1.61Aug 6, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 6, 2026Exercised options 961 shares of Aptevo Therapeutics Inc.⁴
• Jul 17, 2025Exercised options 5 shares of Aptevo Therapeutics Inc.⁵
• Mar 3, 2025Exercised options 2 shares of Aptevo Therapeutics Inc.⁶
• Mar 2, 2025Exercised options 3 shares of Aptevo Therapeutics Inc.⁶
• Aug 8, 2024Exercised options 272 shares of Aptevo Therapeutics Inc.⁷
• Aug 8, 2024Exercised options 42 shares of Aptevo Therapeutics Inc.⁷
• Mar 3, 2024Exercised options 3,667 shares of Aptevo Therapeutics Inc.⁸
• Mar 2, 2024Exercised options 5,500 shares of Aptevo Therapeutics Inc.⁸
• Jan 28, 2024Exercised options 1,833 shares of Aptevo Therapeutics Inc.⁹
• Aug 8, 2023Exercised options 1,833 shares of Aptevo Therapeutics Inc.¹⁰
• Aug 8, 2023Exercised options 11,979 shares of Aptevo Therapeutics Inc.¹⁰
• Mar 3, 2023Exercised options 3,666 shares of Aptevo Therapeutics Inc.¹¹
• Jan 29, 2023Exercised options 1,834 shares of Aptevo Therapeutics Inc.¹²
• Jan 29, 2022Exercised options 1,833 shares of Aptevo Therapeutics Inc.¹³